CB Insights
Technology Market Intelligence
Technology Market Intelligence
Kaitai Capital is a venture capital management company, focusing on biotechnology and precision medicine, medical services, cultural and entertainment, leisure travel, outdoor sports, and financial services.
Phone: +86 571 8531 5990
Phoenix Valley, Fund Town
South of Yuhuang Mountain, Uptown
Hangzhou,
Zhejiang , China
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2021-07-02 | Gaoguang Pharmaceutical | Series B - II | China International Capital Corporation, EFung Capital, and Hankang Equity Investment Management | |
| 2021-06-29 | Huanma Biology | Seed VC | Apricot Capital | |
| 2021-06-17 | Hongyun Biotech | Series B | $15.63M | Cowin Venture, Dayou Capital, Dynamic Balance Investment, and Sherpa Venture Capital |
| 2021-05-06 | BridGene Biosciences | Series A | $12M | Pangu Chuangye, Takeda Ventures, and Wedo Capital |
| 2021-04-07 | PackGene Biotech | Series B - III | Cathay Capital Private Equity, CMB International Capital, Decheng Capital, Guangzhou GET Tech, Oriza Equity Investment, and Sequoia Capital China |
